CDK7 and familial pancreatic carcinoma: In terms of pharmacological mechanisms, although the pharmacological effects of GEM and PTX as conventional chemotherapeutic agents in pancreatic cancer are well established, as we summarize in Fig. 6C, targeted inhibition of CDK7 exhibits substantial synergistic effects with GEM and PTX combination chemotherapy, revealing new prospective therapeutic options for the treatment of PDAC.